Methods and pharmaceutical formulations for treatment of selective estrogen-receptor modulator-induced adverse drug reactions

摘要

The invention related to methods of treatment of an individual suffering from or at risk of suffering from a selective estrogen-receptor modulator (SERM) induced adverse drug reaction. The invention additionally relates to a pharmaceutical dosage form, preferably a tablet, comprising a composition for pulsatile, not-continuous release of a compound or a combination of compounds that stimulate the dopamine and/or the noradrenergic system.